STOCK TITAN

Aesthetic Medical International Holdings Group Limited Filed Annual Report on Form 20-F for 2020

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2020, with the U.S. SEC on April 30, 2021. The report contains audited financial statements, accessible via the SEC's website and the Company's investor relations portal. AIH is a premier provider of aesthetic medical services in China, operating treatment centers in key cities. Notably, it was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018.

Positive
  • Filed Form 20-F annual report with the SEC, ensuring regulatory compliance.
  • The Company is a leading provider in a growing market, highlighted by third-party revenue ranking.
Negative
  • None.

Shenzhen, China, April 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it had filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (the “SEC”) on April 30, 2021/ The annual report on Form 20-F, which contains the Company’s audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at https://ir.aihgroup.net/. Hard copies of the annual report are available, free of charge, to shareholders upon request.

About Aesthetic Medical International Holdings Group Limited

AIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: https://ir.aihgroup.net/.

Investor Relations Contact

For investor and media inquiries, please contact:

Aesthetic Medical International Holdings Group Limited
Email: ir@pengai.com.cn

Ascent Investor Relations LLC
Ms. Tina Xiao
Tel: (917) 609-0333
Email: tina.xiao@ascent-ir.com


FAQ

What is the latest annual report filed by Aesthetic Medical International Holdings Group Limited?

AIH filed its annual report on Form 20-F for the fiscal year ended December 31, 2020, on April 30, 2021.

Where can I access the annual report of AIH?

The annual report can be accessed on the SEC's website and the Company's investor relations website.

What was AIH's position in the Chinese aesthetic medical services market?

AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018.

What services does Aesthetic Medical International Holdings Group Limited offer?

AIH offers surgical and non-surgical aesthetic treatments, along with general medical services.

Aesthetic Medical International Holdings Group Ltd. American Depositary Shares

NASDAQ:AIH

AIH Rankings

AIH Latest News

AIH Stock Data

15.93M
143.36M
0.94%
0.62%
Medical Care Facilities
Healthcare
Link
United States of America
Shenzhen